Astrana Health Debuts on Fortune 1000 After 56% Revenue Surge
Event summary
- Astrana Health landed on the 2026 Fortune 1000 list with $3.18B revenue, up 56% YoY.
- FY2025 adjusted EBITDA hit $205.4M with $104.5M in free cash flow.
- Company supports 20,000 providers and 1.55M patients in value-based care arrangements.
- CEO Brandon Sim credits AI-powered infrastructure and physician-centric model for growth.
The big picture
Astrana's Fortune 1000 debut underscores the accelerating shift toward AI-driven, value-based care models. The company's 56% revenue growth reflects both the scalability of its technology platform and the broader industry move toward outcomes-based reimbursement. With 1.55M patients under value-based arrangements, Astrana is positioning itself as a key infrastructure player in healthcare's digital transformation.
What we're watching
- Sustainability of Growth
- Whether Astrana can maintain 56% YoY revenue growth amid healthcare's shifting value-based care dynamics.
- AI Integration
- The pace at which AI-enabled infrastructure adoption will scale across its 20,000 provider network.
- Market Positioning
- How Astrana's physician-centric model differentiates it in an increasingly consolidated healthcare landscape.
Related topics